Prevalence of CVD and Assessment of CV Risk in Patients with Prostate Cancer
Dr. Alexander Lyon presented “Prevalence of CVD and Assessment of CV Risk in Patients with...
Read MoreSelect Page
Posted by Alexander Lyon, MD, PhD | Feb 2017
Dr. Alexander Lyon presented “Prevalence of CVD and Assessment of CV Risk in Patients with...
Read MorePosted by Laurence Klotz, MD, FRCSC | Feb 2017
Laurence Klotz, MD presented “Active Surveillance or: Shrinking the Gray Zone” at the 6th...
Read MorePosted by E. David Crawford, MD | Feb 2017
E. David Crawford, MD presented “ADT: Mechanisms of CV Disease” at the 6th Symposium on the...
Read MorePosted by Anwar R. Padhani, MBBS, FRCP, FRCR | Feb 2017
Anwar Padhani, MBBS, FRCP, FRCR, presented “Imaging of Metastatic Prostate Cancer: Whole Body MRI...
Read MorePosted by Mohit Khera, MD, MBA, MPH | May 2016
Mohit Khera, MD, MBA, MPH, discusses the shared decision-making model of ED treatment and the current shift toward regenerative therapies.
Read More